Analyses of real world data from US adults with Lp(a) test results have confirmed links between elevated levels and mitral valve disorders and supported previous studies that failed to show a link with atrial fibrillation (AF).1,2
Educational Partners and Supporters
AstraZeneca has provided a sponsorship grant towards this independent programme.
(Founding Partner)
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.
